![]() |
Jan Holgersson, MD, PhD"We are paving the way for the development of mucin-based biopharmaceuticals targeting the vaccine and anti-microbials markets." |
![]() |
Anki Gustafsson, PhD”My focus is on maximizing the full biomedical potential of carbohydrates.” |
![]() |
Tomas Johansson, PhD“My primary objective is to establish the foundation for our purification strategies.” |
![]() |
Nathalie Chatzissavidou”My key responsibility is to develop an effective, robust and scalable fed batch production method for the recombinant mucins. I have simplified the inoculums seed train method and developed a Recopharma proprietary feed composition for the mucine expressing CHO cell lines” |